HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maren Carbon Selected Research

Antipsychotic Agents (Antipsychotics)

10/2018Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis.
3/2017Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis.
3/2016Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis.
11/2015Frequency and correlates of DSM-5 attenuated psychosis syndrome in a sample of adolescent inpatients with nonpsychotic psychiatric disorders.
9/2015Outcome of Youth with Early-Phase Schizophrenia-Spectrum Disorders and Psychosis Not Otherwise Specified Treated with Second-Generation Antipsychotics: 12 Week Results from a Prospective, Naturalistic Cohort Study.
9/2015Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
12/2014Emerging drugs for schizophrenia: an update.
12/2014Clinical predictors of therapeutic response to antipsychotics in schizophrenia.
12/2014Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia.
12/2013Early nonresponse determined by the clinical global impressions scale predicts poorer outcomes in youth with schizophrenia spectrum disorders naturalistically treated with second-generation antipsychotics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maren Carbon Research Topics

Disease

3Schizophrenia (Dementia Praecox)
09/2015 - 12/2013
3Parkinson Disease (Parkinson's Disease)
05/2008 - 08/2002
2Tardive Dyskinesia
10/2018 - 03/2017
2Psychotic Disorders (Schizoaffective Disorder)
11/2015 - 09/2015
1Autism Spectrum Disorder
03/2016
1Type 2 Diabetes Mellitus (MODY)
03/2016
1Parkinsonian Disorders (Parkinsonism)
09/2015
1Dyskinesias (Dyskinesia)
09/2015
1Neurobehavioral Manifestations
12/2014
1Substance-Related Disorders (Drug Abuse)
12/2014
1Hallucinations (Hallucination)
12/2014
1Anxiety Disorders (Anxiety Disorder)
11/2011
1Dystonia (Limb Dystonia)
07/2003
1Dystonia musculorum deformans type 1
07/2003
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2003

Drug/Important Bio-Agent (IBA)

10Antipsychotic Agents (Antipsychotics)IBA
10/2018 - 12/2013
3Quetiapine Fumarate (Seroquel)FDA Link
09/2015 - 11/2011
2ziprasidone (Geodon)FDA Link
09/2015 - 12/2013
2Aripiprazole (Abilify)FDA Link
09/2015 - 12/2013
2Olanzapine (Zyprexa)FDA Link
09/2015 - 12/2013
2Risperidone (Risperdal Consta)FDA LinkGeneric
09/2015 - 12/2013
1Serotonin AntagonistsIBA
10/2018
1Cholinergic Antagonists (Anticholinergics)IBA
09/2015
1Clozapine (Clozaril)FDA LinkGeneric
12/2014
1Levodopa (L Dopa)FDA LinkGeneric
04/2008
1Glucose (Dextrose)FDA LinkGeneric
07/2003

Therapy/Procedure

3Therapeutics
05/2008 - 07/2003
1Deep Brain Stimulation
08/2002